Metanoia Bio

Provider of platform technology to prevent diabetes

placeLos Angeles, California, United States calendar_todayFounded 2020 groups5 employees language metanoia.bio

Innovation

4 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 47 times.

YearFilings
20224
20234
20244
20254

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon